Discover 3,591 paid clinical trials in Fullerton, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,591
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Fullerton CA, Los Angeles CA, Murrieta CA, La Jolla CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase 3, Recruiting
FT839 in Autoimmune Diseases
for
ANCA-Associated Vasculitis (AAV),
Location: Fullerton CA
Sponsor: Fate Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07800871
Phase 1, Phase 2, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Fullerton CA, Orange CA, Los Angeles CA,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for
Radiographic Axial Spondyloarthritis
Location: Fullerton CA, Huntington Beach CA, Upland CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07133633
Phase 2, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Fullerton CA, Orange CA, Duarte CA, Santa Monica CA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for
Breast Cancer
Location: Fullerton CA, Los Angeles CA, Billings MT, Seattle WA,
Sponsor: Celcuity Inc
Sex: All
Age: 18+
Code: NCT06757634
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
for
Esophageal Squamous Cell Carcinoma
Location: Fullerton CA, Orange CA, Phoenix AZ, Fort Worth TX,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06644781
Phase 3, Recruiting
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Fullerton CA, Orange CA, Mission Viejo CA, Burbank CA,
Sponsor: Swedish Medical Center
Sex: All
Age: 18+
Code: NCT07108660
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Fullerton CA, Whittier CA, Long Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase 3, Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Fullerton CA, Newport Beach CA, La Jolla CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06997029
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: Fullerton CA, Los Alamitos CA, Fountain Valley CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Fullerton CA, Vista CA, Encinitas CA, San Diego CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for
Advanced/Metastatic Non-Small Cell Lung Cancer,
Location: Fullerton CA, Los Angeles CA, Panorama City CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227298
Phase 1, Phase 2, Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: Fullerton CA, Tacoma WA, Spokane WA, Tyler TX,
Sponsor: Panbela Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05254171
Phase 2, Phase 3, Recruiting
First in Human Study of TORL-1-23 in Participants With Advanced Cancer